GENEVA (Reuters) - The GAVI vaccine alliance will disburse $29 million to help health systems in 13 lower-income countries fight COVID-19, it said on Thursday, part of a $200 million programme approved by its board last month.
The Geneva-based public–private global health partnership said the first recipients are Myanmar, Democratic Republic of Congo, Ethiopia, Malawi, Afghanistan, Sudan, Zimbabwe, South Sudan, Timor-Leste, Guinea-Bissau, Tajikistan, Bhutan and Liberia.
Roughly 39% of the initial amount will be spent on protective equipment for health workers, with the rest going for diagnostic tests and to boost disease surveillance, spokesman James Fulker said.
Reporting by Stephanie Nebehay
Our Standards: The Thomson Reuters Trust Principles.